Concomitant levosimendan and esmolol infusion in ischaemic cardiogenic shock.
F
F
Guarracino
G
G
Landoni
R
R
Baldassarri
L
L
Nobile
M
M
Stefani
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D011412:Propanolamines / Q000627:therapeutic use*; D011724:Pyridazines / Q000627:therapeutic use*; D012770:Shock, Cardiogenic / Q000188:drug therapy*; D000077464:Simendan
D000319:Adrenergic beta-Antagonists; D002316:Cardiotonic Agents; D006835:Hydrazones; D011412:Propanolamines; D011724:Pyridazines; D000077464:Simendan; C036604:esmolol